According to the Therm Score, Injective (INJUSD) is in the Cold zone today (23.6/100), based on normalized technical positioning relative to its own historical range — the same methodology used for stocks on this site.

No. MarketTherm doesn't forecast prices or set price targets for INJUSD. Cryptocurrencies are scored with the exact same 4-component methodology as stocks (trend, momentum, volatility, volume), but this asset class doesn't yet have its own independent historical validation the way stocks do — no win-rate or "X% of the time" figures are published for it yet.

Injective (INJUSD) rose 3.12% versus the previous session's close. Its Therm Score moved down 0.2 points over the same period, to 23.6 (Cold zone) today. MarketTherm doesn't attribute daily moves to specific news or events.

Over the past 252 trading sessions (roughly a year), INJUSD has traded between 7.13 and 51.95, versus 24.98 today.

Over the past 252 trading sessions (roughly a year), INJUSD's Therm Score has ranged from 0.7 to 99.3, versus 23.6 today.

INJUSD has been in the Cold zone for 5 consecutive sessions as of today. A longer streak means the score has been more persistently in this range recently — it isn't, by itself, a signal to act on.

Today, INJUSD's Therm Score of 23.6 ranks 5 of 5 tracked Crypto (INJUSD included), which range from 23.6 to 73.7 today. This is descriptive context, not a ranking recommendation.

MarketTherm validates each asset class independently before publishing statistics for it — that validation (a historical backtest with a train/test split, the same process described on the Methodology page) hasn't been run for this asset class yet. Every cryptocurrency also carries the Limited Data badge at launch, for the same reason: not enough history has accumulated yet.